Down-regulation of angiotensin II receptors in hypertrophied human myocardium

Clinical and Experimental Pharmacology and Physiology

Volumn 23, Issue 6-7, 1996, Pages 514-518

  Nozawa, Yoshihisa ^a   Miyake, Hidekazu ^a   Haruno, Akihiro ^a   Yamada, Shizuo ^b   Uchida, Shinya ^b   Ohkura, Takashi ^b   Kimura, Ryohei ^b   Suzuki, Harumi ^c   Hoshino, Tsuneo ^c  

^a TAIHO PHARMACEUTICAL CO LTD   (Japan)

^b UNIVERSITY OF SHIZUOKA   (Japan)

^c SHIZUOKA GENERAL HOSPITAL   (Japan)

Author keywords

angiotensin II receptors; cardiac hypertrophy; human myocardium; receptor subtype; 125I angiotensin II

Indexed keywords

ANGIOTENSIN 2 RECEPTOR; LOSARTAN; RECEPTOR SUBTYPE;

ARTICLE; BINDING KINETICS; BINDING SITE; DISSOCIATION CONSTANT; HEART VENTRICLE HYPERTROPHY; HUMAN; HUMAN TISSUE; RECEPTOR BINDING; RECEPTOR DOWN REGULATION;

EID: 0029947109     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1681.1996.tb02771.x     Document Type: Article

References (39)

1. Anderson KM, Odell PM, Wilson PWF, Kannel WB. Cardiovascular disease risk profiles. Am. Heart J. 1990; 121: 293-8.
2. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N. Engl. J. Med. 1990; 322: 1561-6.
3. Vandenburgh HH. Mechanical forces and their second messengers in stimulating cell growth in vitro. Am. J. Physiol. 1992; 262: R350-5.
4. Schneider MD, Parker TG. Cardiac growth factors. Prog. Growth Factor Res. 1991; 3: 1-26.
5. Schunkert H, Dzau VJ, Tang SS, Hirsch AT, Apstein CS, Lorell BH. Increased rat cardiac angiotensin-converting enzyme activity and mRNA levels in pressure overload left ventricular hypertrophy: Effects on coronary resistance, contractility and relaxation. J. Clin. Invest. 1990; 86: 1913-20.
6. Schunkert H, Ingelfinger JR, Hirsch AT et al. Feedback regulation of angiotensin converting enzyme activity and mRNA levels by angiotensin II. Circ. Res. 1993; 72: 312-18.
7. Pfeffer JM, Pfeffer MA, Mirsky I, Braunwald E. Regression of left ventricular hypertrophy and prevention of left ventricular dysfunction by captopril in the spontaneously hypertensive rat. Proc. Natl Acad Sci. USA 1982; 79: 3310-14.
8. Kromer EP, Riegger GAJ. Effects of long-term angiotensin converting enzyme inhibition on myocardial hypertrophy in experimental aortic stenosis in the rat. Am. J. Cardiol. 1988; 62: 161-3.
9. Linz W, Scholkens BA, Ganten D. Converting enzyme inhibition specifically prevents the development and induces regression of cardiac hypertrophy in rats. Clin. Exp. Hypertens. 1989; 11: 1325-50.
10. Schieffer B, Wirger A, Meybrunn M et al. Comparative effects of chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade on cardiac remodeling after myocardial infarction in the rat. Circulation 1994; 89: 2273-82.
11. Regitz-Zagrosek V, Friedel N, Schuler S, Heymann A, Ruland H, Flech E. Loss of myocardial angiotensin II receptors in end-stage human heart failure. Circulation 1993; 88: 1475.
12. Baker KM, Aceto JF. Angiotensin II stimulation of protein synthesis and cell growth in chick heart cells. Am. J. Physiol. 1990; 259: H610-18.
13. Sadoshima J, Xu Y, Slayter HS, Izumo S. Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro. Cell 1993; 75: 977-84.
14. Baker KM, Campanile CP, Trachte GJ, Peach MJ. Identification and characterization of rabbit angiotensin II myocardial receptor. Circ. Res. 1984; 54: 286-93.
15. Urata H, Heal B, Stewart RW, Bumpus FM, Husain A. Angiotensin II receptors in normal and failing human hearts. J. Clin. Endocrinol. Metab. 1989; 69: 54-66.
16. Sechi LA, Griffin CA, Grady EF, Kalinyak JE, Schambelan M. Characterization of angiotensin II receptor subtypes in rat heart. Circ. Res. 1992; 71: 1482-9.
17. DeGasparo M, Rogg H, Brink M et al. Angiotensin II receptor subtypes and cardiac function. Eur. Heart J. 1994; 15: 98-103.
18. Nozawa Y, Haruno A, Oda N et al. Angiotensin II receptor subtypes in bovine and human ventricular myocardium. J. Pharmacol. Exp. Ther. 1994; 270: 566-71.
19. 1 receptor. Am. J. Hypertens. 1992; 5: 276-80.
20. Mizuno K, Niimura S, Katoh K, Fukuchi S. TCV-116, a newly developed angiotensin II receptor antagonist, induced regression of cardiac hypertrophy through suppression of the tissue renin-angiotensin system in spontaneously hypertensive rats. Life Sci. 1994; 54: 1987-94.
21. Ipata PL. A coupled optical enzyme assay for 5′-nucleotidase. Anal. Biochem. 1967; 20: 30-6.
22. Bradford MM. A rapid and sensitive method for quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976; 72: 248-54.
23. 2-adrenoceptors in intact human lymphocytes. Arch. Int. Pharmacodyn. Ther. 1984; 272: 324-39.
24. 3H]WB4101: Effects of 6-hydroxydopamine treatment. J. Pharmacol. Exp. Ther. 1980; 215: 176-85.
25. Scatchard G. The attraction of proteins for small molecules and ions. Ann. N. Y. Acad. Sci. 1949; 51: 660-72.
26. 2-adrenoceptor in the human heart: Properties, function, and alterations in chronic heart failure. Pharmacol. Rev. 1991; 43: 203-42.
27. Wiest SA, Rampersaud A, Zimmerman K, Steinberg MI. Characterization of distinct angiotensin II binding sites in rat adrenal gland and bovine cerebellum using selective nonpeptide antagonists. J. Cardiovasc. Pharmacol 1991; 17: 117-84.
28. Neuβ M, Regitz-Zagrosek V, Hildebrandt A, Flech E. Human cardiac fibroblasts express an angiotensin receptor with unusual binding characteristics which is coupled to cellular proliferation. Biochem. Biophys. Res. Commun. 1994; 204: 1334-9.
29. Nakashima Y, Fouad FM, Tarazi RC. Regression of left ventricular hypertrophy from systemic hypertension by enalapril. Am. J. Cardiol. 1984; 53: 1044-9.
30. Eichstaedt H, Danne O, Langer M et al. Regression left ventricular hypertrophy under ramipril treatment investigated by nuclear magnetic resonance imaging. J. Cardiovasc. Pharmacol. 1989; 13: S75-80.
31. Dahlof B, Pennert K, Hansson L. Regression of left ventricular hypertrophy: A meta-analysis. Clin. Exp. Hypertens. 1992; A14: 173-80.
32. 2 receptors in the developing rat fetus. J. Clin. Invest. 1991; 88: 921-33.
33. Pfeffer MA, Braunwald E, Moye E et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: Results of the survival and ventricular enlargement trial. N. Engl. J. Med. 1992; 327: 669-77.
34. 2-receptor subtypes in hypertrophied rat hearts. Am. J. Physiol. 1994; 267: H844-52.
35. 2 angiotensin II receptor subtypes in the rat brain during development. Proc. Natl Acad. Sci. USA 1991; 88: 11 440-4.
36. Viswanathan M, Tsutsumi K, Correa FMA, Saavedra JM. Changes in expression of angiotensin receptor subtypes in the rat aorta during development. Biochem. Biophys. Res. Commun. 1991; 179: 1361-7.
37. Nio Y, Matsubara H, Murasawa S, Kanasaki M, Inad M. Regulation of gene transcription of angiotensin II receptor subtypes in myocardial infarction. J. Clin. Invest. 1995; 95: 46-54.
38. Janiak P, Pillon A, Prost JF, Vialine, JP. Role of angiotensin subtype 2 receptor in neointima formation after vascular injury. Hypertension 1992; 20: 737-45.
39. 2-receptor mediates inhibition of cell proliferation in coronary endothelial cells. J. Clin. Invest. 1995; 95: 651-7.